The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 25, 2026 | Keel Paul A | Chief Executive Officer, Director | Tax withholding(F) | 13K | $23.43 | $300K |
| May 19, 2026 | Raskas Daniel | Director | Grant(A) | 9K | — | $0 |
| May 19, 2026 | Carruthers Wendy | Director | Grant(A) | 9K | — | $0 |
| May 19, 2026 | Gallahue Kieran | Director | Grant(A) | 9K | — | $0 |
| May 19, 2026 | Huennekens R Scott | Director | Grant(A) | 13K | — | $0 |
| May 19, 2026 | Jain Vivek | Director | Grant(A) | 9K | — | $0 |
| May 19, 2026 | Pierce James Andrew | Director | Grant(A) | 9K | — | $0 |
| May 19, 2026 | Tsingos Christine A | Director | Grant(A) | 9K | — | $0 |
| Feb 25, 2026 | Hammes Eric D. | Chief Financial Officer | Tax withholding(F) | 2K | $29.59 | $61K |
| Feb 25, 2026 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 16K | — | $0 |
| Feb 25, 2026 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 38K | — | $0 |
| Feb 25, 2026 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 29K | — | $0 |
| Feb 25, 2026 | Keel Paul A | Chief Executive Officer, Director | Grant(A) | 49K | — | $0 |
| Feb 25, 2026 | Keel Paul A | Chief Executive Officer, Director | Tax withholding(F) | 12K | $29.59 | $350K |
| Feb 25, 2026 | Keel Paul A | Chief Executive Officer, Director | Grant(A) | 133K | — | $0 |
| Feb 25, 2026 | Keel Paul A | Chief Executive Officer, Director | Grant(A) | 115K | — | $0 |
| Feb 25, 2026 | Nance Mark E | General Counsel | Grant(A) | 13K | — | $0 |
| Feb 25, 2026 | Nance Mark E | General Counsel | Tax withholding(F) | 3K | $29.59 | $100K |
| Feb 25, 2026 | Nance Mark E | General Counsel | Grant(A) | 23K | — | $0 |
| Feb 25, 2026 | Nance Mark E | General Counsel | Grant(A) | 30K | — | $0 |
| Feb 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Tax withholding(F) | 3K | $29.59 | $88K |
| Feb 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 6K | — | $0 |
| Feb 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 11K | — | $0 |
| Feb 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 14K | — | $0 |
| Feb 25, 2026 | Kaabi Faez C | Chief Accounting Officer | Tax withholding(F) | 5K | $29.59 | $147K |
| Feb 25, 2026 | Kaabi Faez C | Chief Accounting Officer | Grant(A) | 14K | — | $0 |
| Feb 25, 2026 | Befidi Robert | President, Diagnostics | Tax withholding(F) | 2K | $29.59 | $64K |
| Feb 25, 2026 | Befidi Robert | President, Diagnostics | Grant(A) | 8K | — | $0 |
| Feb 25, 2026 | Befidi Robert | President, Diagnostics | Grant(A) | 18K | — | $0 |
| Feb 25, 2026 | Befidi Robert | President, Diagnostics | Grant(A) | 14K | — | $0 |
| Feb 25, 2026 | Nilsson Stefan | President, Nobel Biocare | Tax withholding(F) | 182 | $29.59 | $5K |
| Feb 25, 2026 | Nilsson Stefan | President, Nobel Biocare | Grant(A) | 8K | — | $0 |
| Feb 25, 2026 | Nilsson Stefan | President, Nobel Biocare | Grant(A) | 14K | — | $0 |
| Feb 25, 2026 | Nilsson Stefan | President, Nobel Biocare | Grant(A) | 18K | — | $0 |
| Feb 25, 2026 | Acurio Veronica | President, Orthodontics | Tax withholding(F) | 1K | $29.59 | $42K |
| Feb 25, 2026 | Acurio Veronica | President, Orthodontics | Grant(A) | 8K | — | $0 |
| Feb 25, 2026 | Acurio Veronica | President, Orthodontics | Grant(A) | 18K | — | $0 |
| Feb 25, 2026 | Acurio Veronica | President, Orthodontics | Grant(A) | 14K | — | $0 |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Sell(S) | 6K | $30.00 | $169K |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Sell(S) | 4K | $30.00 | $121K |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Option exercise(M) | 4K | $19.04 | $77K |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Option exercise(M) | 6K | $15.97 | $90K |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Option exercise(M) | 4K | — | $0 |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Option exercise(M) | 6K | — | $0 |
| Feb 1, 2026 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 1K | $23.47 | $26K |
| Feb 1, 2026 | Keel Paul A | Chief Executive Officer, Director | Grant(A) | 4K | $23.47 | $96K |
| Feb 1, 2026 | Nance Mark E | General Counsel | Grant(A) | 2K | $23.47 | $47K |
| Feb 1, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 3K | $21.71 | $63K |
| Feb 1, 2026 | Kaabi Faez C | Chief Accounting Officer | Grant(A) | 1K | $23.47 | $28K |
| Feb 1, 2026 | Befidi Robert | President, Diagnostics | Grant(A) | 998 | $23.47 | $23K |
| Feb 1, 2026 | Acurio Veronica | President, Orthodontics | Grant(A) | 998 | $23.47 | $23K |
| Nov 1, 2025 | Keel Paul A | Chief Executive Officer, Director | Tax withholding(F) | 54K | $20.35 | $1.1M |
| Aug 25, 2025 | Hammes Eric D. | Chief Financial Officer | Tax withholding(F) | 8K | $21.12 | $162K |
| Aug 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | Sell(S) | 15K | $21.60 | $324K |
| Aug 25, 2025 | Befidi Robert | President, Diagnostics | Tax withholding(F) | 3K | $21.12 | $73K |
| Aug 25, 2025 | Nilsson Stefan | President, Nobel Biocare | Tax withholding(F) | 804 | $21.12 | $17K |
| Aug 25, 2025 | Acurio Veronica | President, Orthodontics | Tax withholding(F) | 5K | $21.12 | $115K |
| Jul 14, 2025 | Pierce James Andrew | Director | Grant(A) | 9K | — | $0 |
| Jun 10, 2025 | Huennekens R Scott | Director | Grant(A) | 14K | — | $0 |
| Jun 10, 2025 | Hulit Barbara B. | Director | Grant(A) | 10K | — | $0 |
| Jun 10, 2025 | Tsingos Christine A | Director | Grant(A) | 10K | — | $0 |
| Jun 10, 2025 | Carruthers Wendy | Director | Grant(A) | 10K | — | $0 |
| Jun 10, 2025 | Jain Vivek | Director | Grant(A) | 10K | — | $0 |
| Jun 10, 2025 | Raskas Daniel | Director | Grant(A) | 10K | — | $0 |
| Jun 10, 2025 | Gallahue Kieran | Director | Grant(A) | 10K | — | $0 |
| May 25, 2025 | Keel Paul A | Chief Executive Officer, Director | Tax withholding(F) | 13K | $16.72 | $214K |
| Feb 26, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 8K | — | $0 |
| Feb 25, 2025 | Nance Mark E | General Counsel | Grant(A) | 18K | — | $0 |
| Feb 25, 2025 | Nance Mark E | General Counsel | Tax withholding(F) | 4K | $20.66 | $76K |
| Feb 25, 2025 | Nance Mark E | General Counsel | Grant(A) | 33K | — | $0 |
| Feb 25, 2025 | Nance Mark E | General Counsel | Grant(A) | 42K | — | $0 |
| Feb 25, 2025 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 16K | — | $0 |
| Feb 25, 2025 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 37K | — | $0 |
| Feb 25, 2025 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 29K | — | $0 |
| Feb 25, 2025 | Befidi Robert | President, Diagnostics | Tax withholding(F) | 1K | $20.66 | $23K |
| Feb 25, 2025 | Befidi Robert | President, Diagnostics | Grant(A) | 10K | — | $0 |
| Feb 25, 2025 | Befidi Robert | President, Diagnostics | Grant(A) | 24K | — | $0 |
| Feb 25, 2025 | Befidi Robert | President, Diagnostics | Grant(A) | 19K | — | $0 |
| Feb 25, 2025 | Nilsson Stefan | President, Nobel Biocare | Grant(A) | 10K | — | $0 |
| Feb 25, 2025 | Nilsson Stefan | President, Nobel Biocare | Grant(A) | 19K | — | $0 |
| Feb 25, 2025 | Nilsson Stefan | President, Nobel Biocare | Grant(A) | 24K | — | $0 |
| Feb 25, 2025 | Acurio Veronica | President, Orthodontics | Grant(A) | 10K | — | $0 |
| Feb 25, 2025 | Acurio Veronica | President, Orthodontics | Grant(A) | 24K | — | $0 |
| Feb 25, 2025 | Acurio Veronica | President, Orthodontics | Grant(A) | 19K | — | $0 |
| Feb 25, 2025 | Keel Paul A | Chief Executive Officer, Director | Grant(A) | 66K | — | $0 |
| Feb 25, 2025 | Keel Paul A | Chief Executive Officer, Director | Grant(A) | 182K | — | $0 |
| Feb 25, 2025 | Keel Paul A | Chief Executive Officer, Director | Grant(A) | 154K | — | $0 |
| Feb 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | Tax withholding(F) | 4K | $20.66 | $79K |
| Feb 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 20K | — | $0 |
| Feb 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 16K | — | $0 |
| Feb 25, 2025 | Kaabi Faez C | Chief Accounting Officer | Grant(A) | 10K | — | $0 |
| Feb 25, 2025 | Kaabi Faez C | Chief Accounting Officer | Tax withholding(F) | 4K | $20.66 | $89K |
| Feb 25, 2025 | Kaabi Faez C | Chief Accounting Officer | Grant(A) | 23K | — | $0 |
| Feb 1, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | Grant(A) | 3K | $20.52 | $65K |
| Feb 1, 2025 | Kaabi Faez C | Chief Accounting Officer | Grant(A) | 689 | $20.52 | $14K |
| Feb 1, 2025 | Nance Mark E | General Counsel | Grant(A) | 965 | $20.52 | $20K |
| Feb 1, 2025 | Befidi Robert | President, Diagnostics | Grant(A) | 1K | $20.52 | $24K |
| Nov 1, 2024 | Keel Paul A | Chief Executive Officer, Director | Tax withholding(F) | 54K | $20.94 | $1.1M |
| Sep 17, 2024 | Reis Mischa | SVP, Strategy & Bus. Dev. | Tax withholding(F) | 812 | $19.00 | $15K |
| Aug 25, 2024 | Hammes Eric D. | Chief Financial Officer | Grant(A) | 64K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).